Journal
JOURNAL OF IMMUNOLOGY
Volume 202, Issue 2, Pages 392-398Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1801054
Keywords
-
Categories
Funding
- National Institute of Allergy and Infectious Diseases (NIAID) [T32AI106700-02]
- NIAID [HHSN272201400006C]
- ALSAC
Ask authors/readers for more resources
The severity of the 2017-18 influenza season, combined with the low efficacy for some vaccine components, highlights the need to improve our current seasonal influenza vaccine. Thus, the National Institute of Allergy and Infectious Diseases recently announced a strategic plan to improve current influenza vaccines and eventually develop a universal influenza vaccine. This review will highlight the many different strategies being undertaken in pursuit of this goal and the exciting advances made by the influenza community. There is no doubt that an improved influenza vaccine is on the horizon.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available